Washington Post Publisher Will Lewis Steps Down After Layoffs 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
BURLINGTON, Mass., Nov. 01, 2017 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be participating in six investor conferences in November and December.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Medical Technologies & Diagnostics Forum on Thursday, November 9, 2017 at the Westin Grand Central Hotel in New York City. The Company’s presentation is scheduled to begin at 11:30 AM EST.
David Roberts, President, is scheduled to present at the Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at the Lotte New York Palace Hotel in New York City. The Company’s presentation is scheduled to begin at 2:45 PM EST.
Steven Chehames, Investor Relations, is scheduled to present at the Three Part Advisors Southwest IDEAS Conference on Thursday, November 16, 2017 at the Westin Dallas Hotel in Dallas. The Company’s presentation is scheduled to begin at 8:40 AM CST.
George LeMaitre, Chairman & CEO, will participate in the Craig-Hallum Alpha Select Conference on Thursday, November 16, 2017 at the Sheraton New York Times Square Hotel in New York City.
David Roberts, President, is scheduled to present at the Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 at the Lotte New York Palace Hotel in New York City. The Company’s presentation is scheduled to begin at 11:10 AM EST.
David Roberts, President, will participate in the Guggenheim Annual Boston Healthcare Conference on Wednesday, December 13, 2017 at the InterContinental Hotel in Boston.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
